Onsdag 28 Oktober | 19:02:16 Europe / Stockholm

All ägardata du vill ha finns i Holdings!

Lipum Q3’22 - We have liftoff

2022-11-25 11:00:00

Redeye leaves a comment on the Q3 report published by Lipum earlier this morning. A quarter marked by the historical initiation of the first clinical trial with the company’s lead candidate, SOL-116.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking.